Croda has announced the acquisition of Enza Biotech, a Swedish renewable surfactants company.
Enza Biotech was founded in 2012 by researchers at Lund University, who were developing renewable surfactants using carbohydrate-based chemistry.
Today Enzo Biotech aims to be a key player in the transition from a fossil-dependent to a bio-based society.
Enza’s first line of green molecules are oligomeric alkyl glycosides, or OLMAG surfactants, which offer both functional and toxicological advantages, according to the company.
Croda believes Enza’s patented technology will enhance its natural and renewable portfolio, especially in personal care, health care and crop care.
Steve Foots, Chief Executive of Croda, said: “Enza Biotech offers a fantastic opportunity for us to fill an identified technology gap in the surfactants market using natural and renewable raw materials.
“It is a great fit as sustainability underpins our growth strategy and is an area that already sets us apart in the eyes of our customers.”
